文献类型：期刊文献

英文题名：Valproic Acid: A Potential Therapeutic for Spinal Cord Injury

作者：Zhou, Conghui[1];Hu, Songfeng[2];Botchway, Benson O. A.[3];Zhang, Yong[1];Liu, Xuehong[1]

机构：[1]Shaoxing Univ, Dept Histol & Embryol, Med Coll, Shaoxing 312000, Zhejiang, Peoples R China;[2]Shaoxing Hosp Tradit Chinese Med, Dept Orthoped, Shaoxing 312000, Zhejiang, Peoples R China;[3]Zhejiang Univ, Sch Med, Inst Neurosci, Hangzhou, Peoples R China

年份：2021

卷号：41

期号：7

起止页码：1441

外文期刊名：CELLULAR AND MOLECULAR NEUROBIOLOGY

收录：SCI-EXPANDED(收录号：WOS:000553277100001)、、Scopus(收录号：2-s2.0-85088584779)、WOS

基金：This work was supported by the Natural Science Foundation of Zhejiang Province (Grant No. LY19H170001).

语种：英文

外文关键词：Valproic acid; mTOR signaling pathway; Inflammation; Autophagy; Spinal cord injury

外文摘要：The lack of an effective pharmaceutical agent for spinal cord injury (SCI) is a current problematic situation for clinicians, as the rate of motor vehicle accidents among young adults is on the rise. SCI contributes to the high disability rate. Presently, evidences detailing the precise pathological mechanisms in SCI are limited, compounding to the unavailability of an effective treatment method. Surgery, though not a complete curative method, is useful in managing some of the associated symptoms of secondary SCI. Autophagy and inflammation are contributive factors to both exacerbation and improvement of SCI. The mammalian target of rapamycin (mTOR) signaling pathway is a key player in the regulation of inflammatory response and autophagy. Valproic acid (VPA), a clinically used antiepileptic drug, has been suggested to improve neurological conditions, including SCI. This report reviewed the correlation between mTOR and autophagy, as well as autophagy's role and the therapeutic effects of VPA in SCI. VPA regulates autophagy by potentially inhibiting mTORC1, a complex of mTOR, while also hindering inflammatory response. Conclusively, an effective treatment for SCI could lie in the timely regulation of mTOR signaling pathway, and VPA could be the potential drug that improves SCI owing to its propensity to regulate the mTOR signaling pathway.